Advocacy Actions
Debrief “Buy China” issue updates in 2020 to the EU Delegation and the European Commission Trade Section
On 18 August, the medical device sector debriefed the "Buy China" updates in 2020 to the EU Delegation and shared with COCIR and updated it to the European Commission Trade Section.
Read moreMeeting with Guangzhou Development District Investment Promotion Bureau on Development of the Medical Device Industry
The Healthcare Equipment (HCE) Working Group hold a meeting with the Guangzhou Development District Investment Promotion Bureau on Development of the Medical Device Industry.
Read moreSent the Review Report of the Center for Medical Device Evaluation Reform to the National Medical Products Administration and the Center for Medical Device Evaluation
On 11 August, the medical device sector sent the review report of the Center for Medical Device Evaluation Reform to the National Medical Products Administration and the Center for Medical Device Evaluation.
Read moreSubmitted comments on the Draft Revision of the Product Quality Law to SAMR
Submitted comments on the Draft Revision of the Product Quality Law to SAMR
Read moreComments on the NHSA's "Establishment of a Medical Product Prices and Tendering Credit Evaluation System "
The Healthcare Equipment (HCE) and the Pharmaceuticals Working Group jointly submitted comments on the National Healthcare Securities (NHSA's) draft "Establishment of a Medical Product Prices and Tendering Credit Evaluation System "
Read moreComments on the Guiding Opinions on the Establishment of Medical Price and Bidding Credit Evaluation System to the National Healthcare Security Administration
European Chamber Pharmaceutical and Healthcare Equipment working groups submitted comments on the Guiding Opinions on the Establishment of Medical Price and Bidding Credit Evaluation System to the NHSA
Read moreAdvocacy Letter on the Periodic Risk Evaluation Report submitted to the Centre for Drug Re-evaluation
On 20 July, the medical device sector sent an advocacy letter to the Centre for Drug Re-evaluation re the implementation of Periodic Risk Evaluation Report.
Read moreHad a joint working group meeting and discussion on the Product Quality Law revision
Had a joint working group meeting and discussion on the Product Quality Law revision
Read moreComments on the NHSA's Draft "Measures for the Management of Consumable Devices in the Basic Health Insurance"
The Healthcare Equipment (HCE) Working Group submitted comments on the National Health Securities Administration's (NHSA's) draft "Measures for the Management of Consumable Devices in the Basic Health Insurance".
Read moreComments to the CMDE to the draft Technical Review Guidelines for Human Factors in Design of Medical Devices
On 28 June, the medical device sector sent comments to Centre for Medical Device Evaluation on the draft Technical Review Guidelines for Human Factors in Design of Medical Devices.
Read more